Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Shares Rise on Plans for 3-for-2 Stock Split

NEW YORK (GenomeWeb News) - Clinical Data’s board of directors yesterday approved a 3-for-2 stock split that will give company stockholders one new share of common stock for every two shares they own.
 
The news drove the company's share price up nearly 13 percent to close at $34.38 yesterday. In late morning trading today, the company's shares had pulled back slightly to $33.96. 
 
The split will occur Sept. 24, and the dividends will be distributed on Oct. 2, the company said.
 
When the split is complete, the company will have a total of around $20.5 million shares outstanding.
 
Company President and CEO Drew Fromkin said the split "reflects the confidence we have in the prospects of our company," and said it is "an opportunity to broaden our base of investors by making our stock more accessible while improving its liquidity.”

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.